Oxford BioDynamics (LSE:OBD) Cash-to-Debt : 0.82 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Oxford BioDynamics's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.82.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Oxford BioDynamics couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Oxford BioDynamics's Cash-to-Debt or its related term are showing as below:

LSE:OBD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.16 Med: No Debt Max: No Debt
Current: 0.82

During the past 11 years, Oxford BioDynamics's highest Cash to Debt Ratio was No Debt. The lowest was 0.16. And the median was No Debt.

LSE:OBD's Cash-to-Debt is ranked worse than
79.6% of 1539 companies
in the Biotechnology industry
Industry Median: 6.51 vs LSE:OBD: 0.82

Oxford BioDynamics Cash-to-Debt Historical Data

The historical data trend for Oxford BioDynamics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Oxford BioDynamics Cash-to-Debt Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

21.27

0.66

0.16

0.82

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial														0.66	0.71	0.16	0.63	0.82

Competitive Comparison of Oxford BioDynamics's Cash-to-Debt

For the Biotechnology subindustry, Oxford BioDynamics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Cash-to-Debt falls into.

Oxford BioDynamics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Oxford BioDynamics's Cash to Debt Ratio for the fiscal year that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.25	/	(0.818	+	5.621)
	=	0.82

Oxford BioDynamics's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.25	/	(0.818	+	5.621)
	=	0.82

Oxford BioDynamics (LSE:OBD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Oxford BioDynamics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (LSE:OBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

OXBOF:USA

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines